Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00343187
Status:
TERMINATED
Last Update Posted:
2011-05-30
First Post:
2006-06-20
Brief Title:
A Phase II Study of ACZONE Dapsone Gel 5 As a Treatment For Tarceva ErlotinibRelated Rash
Sponsor:
Allergan
Organization:
Allergan
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2007-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-06-20
First Submit QC Date:
June 20 2006
Study First Post Date:
2006-06-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-05-27
Last Update Post Date:
2011-05-30
Last Update Post Date Type:
ESTIMATED